5-Year GWAS Reveals Genetic Predictors of Humatrope Response in American Males with GHD
Reading Time: 2 minutes Introduction Growth hormone deficiency (GHD) is a medical condition that can significantly impact the physical development and overall health of affected individuals. In the United States, Humatrope, a recombinant human growth hormone, has been widely used to treat GHD in males. However, the response to Humatrope varies among patients, prompting researchers to investigate the genetic factors that may influence its efficacy. This article presents the findings of a groundbreaking 5-year genome-wide association study (GWAS) conducted on American males with GHD, shedding light on the genetic predictors of Humatrope response. Study Design and Methodology The GWAS involved a cohort of 500...


